AUTHOR INDEX
| |
|
|
|
|
|
Search results for: "S"
Results 141 - 150 of 1023 shown below |
|
| Saxena, Sanjaya |
|
| Sanjaya Saxena, Arthur L Brody, Karron M Maidment, Jennifer J Dunkin, Mark Colgan, Shervin Alborzian, Michael E Phelps and Lewis R Baxter Localized Orbitofrontal and Subcortical Metabolic Changes and Predictors of Response to Paroxetine Treatment in Obsessive-Compulsive Disorder doi:10.1016/S0893-133X(99)00082-2 Neuropsychopharmacology 21, 683-693 | Abstract | Full text | PDF | |
|
| Arthur L Brody, Mark A Mandelkern, Richard E Olmstead, Zoe Allen-Martinez, David Scheibal, Anna L Abrams, Matthew R Costello, Judah Farahi, Sanjaya Saxena, John Monterosso and Edythe D London Ventral Striatal Dopamine Release in Response to Smoking a Regular vs a Denicotinized Cigarette doi:10.1038/npp.2008.87 Neuropsychopharmacology 34, 282-289 | Abstract | Full text | PDF | |
|
| Scanlan, Victoria F |
|
| Elizabeth M Byrnes, Robert S Bridges, Victoria F Scanlan, Jessica A Babb and John J Byrnes Sensorimotor Gating and Dopamine Function in Postpartum Rats doi:10.1038/sj.npp.1301222 Neuropsychopharmacology 32, 1021-1031 | Abstract | Full text | PDF | |
|
| Scanley, Barbara Ellen |
|
| Thomas R Kosten, Barbara Ellen Scanley, Karen A Tucker, Alison Oliveto, Chekema Prince, Rajita Sinha, Marc N Potenza, Pawel Skudlarski and Bruce E Wexler Cue-Induced Brain Activity Changes and Relapse in Cocaine-Dependent Patients doi:10.1038/sj.npp.1300851 Neuropsychopharmacology 31, 644-650 | Abstract | Full text | PDF | |
|
| Scarchilli, Laura |
|
| Patrizia Popoli, Antonella Pèzzola, Maria Torvinen, Rosaria Reggio, Annita Pintor, Laura Scarchilli, Kjell Fuxe and Sergi Ferrè The Selective mGlu5 Receptor Agonist CHPG Inhibits Quinpirole-Induced Turning in 6-Hydroxydopamine-Lesioned Rats and Modulates the Binding Characteristics of Dopamine D2 Receptors in the Rat Striatum Interactions with Adenosine A doi:10.1016/S0893-133X(01)00256-1 Neuropsychopharmacology 25, 505-513 | Abstract | Full text | PDF | |
|
| Scarmeas, Nikolaos |
|
| Davangere P Devanand, Christian G Habeck, Matthias H Tabert, Nikolaos Scarmeas, Gregory H Pelton, James R Moeller, Brett D Mensh, Tyler Tarabula, Ronald L Van Heertum and Yaakov Stern PET Network Abnormalities and Cognitive Decline in Patients with Mild Cognitive Impairment doi:10.1038/sj.npp.1300942 Neuropsychopharmacology 31, 1327-1334 | Abstract | Full text | PDF | |
|
| Scarna, Hélène |
|
| Fany Panayi, Joyce Colussi-Mas, Laura Lambás-Señas, Bernard Renaud, Hélène Scarna and Anne Bérod Endogenous Neurotensin in the Ventral Tegmental Area Contributes to Amphetamine Behavioral Sensitization doi:10.1038/sj.npp.1300638 Neuropsychopharmacology 30, 871-879 | Abstract | Full text | PDF | |
|
| Klara Felszeghy, José Manuel Espinosa, Hélène Scarna, Anne Bérod, William Rostène and Didier Pélaprat Neurotensin Receptor Antagonist Administered during Cocaine Withdrawal Decreases Locomotor Sensitization and Conditioned Place Preference doi:10.1038/sj.npp.1301382 Neuropsychopharmacology 32, 2601-2610 | Abstract | Full text | PDF | |
|
| Scarna, Helene |
|
| Fany Panayi, Erwan Dorso, Laura Lambas-Senas, Bernard Renaud, Helene Scarna and Anne Berod Chronic Blockade of Neurotensin Receptors Strongly Reduces Sensitized, but Not Acute, Behavioral Response to D-amphetamine doi:10.1016/S0893-133X(01)00354-2 Neuropsychopharmacology 26, 64-74 | Abstract | Full text | PDF | |
|
| Scarr, Elizabeth |
|
| Elizabeth Scarr, Monica Beneyto, James H Meador-Woodruff and Brian Dean Cortical Glutamatergic Markers in Schizophrenia doi:10.1038/sj.npp.1300758 Neuropsychopharmacology 30, 1521-1531 | Abstract | Full text | PDF | |
|
| Brian Dean, Monica Beneyto, James Meador-Woodruff, Robert McCullumsmith and Elizabeth Scarr Reply: Autoradiography of [3H]aspartate and Glutamate Transport in Schizophrenia doi:10.1038/sj.npp.1300978 Neuropsychopharmacology 31, 687-688 | Abstract | Full text | PDF | |
|
| Hasib Salah-Uddin, Elizabeth Scarr, Geoffrey Pavey, Kriss Harris, Jim J Hagan, Brian Dean, R A John Challiss and Jeannette M Watson Altered M1 Muscarinic Acetylcholine Receptor (CHRM1)-G q/11 Coupling in a Schizophrenia Endophenotypedoi:10.1038/npp.2009.41 Neuropsychopharmacology 34, 2156-2166 | Abstract | Full text | PDF | |
|
| Scatton, Bernard |
|
| Ronan Depoortere, Denis Boulay, Ghislaine Perrault, Olivier Bergis, Michel Decobert, Dominique Françon, Mireille Jung, Jacques Simiand, Philippe Soubrié and Bernard Scatton SSR181507, A Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist. II: Behavioral Profile Predictive of an Atypical Antipsychotic Activity doi:10.1038/sj.npp.1300261 Neuropsychopharmacology 28, 1889-1902 | Abstract | Full text | PDF | |
|
| Ronan Depoortère, Gihad Dargazanli, Genevieve Estenne-Bouhtou, Annick Coste, Christophe Lanneau, Christophe Desvignes, Martine Poncelet, Michel Heaulme, Vincent Santucci, Michel Decobert, Annie Cudennec, Carolle Voltz, Denis Boulay, Jean Paul Terranova, Jeanne Stemmelin, Pierre Roger, Benoit Marabout, Mireille Sevrin, Xavier Vigé, Bruno Biton, Régis Steinberg, Dominique Françon, Richard Alonso, Patrick Avenet, Florence Oury-Donat, Ghislaine Perrault, Guy Griebel, Pascal George, Philippe Soubrié and Bernard Scatton Neurochemical, Electrophysiological and Pharmacological Profiles of the Selective Inhibitor of the Glycine Transporter-1 SSR504734, a Potential New Type of Antipsychotic doi:10.1038/sj.npp.1300772 Neuropsychopharmacology 30, 1963-1985 | Abstract | Full text | PDF | |
|
| Philippe Pichat, Olivier E Bergis, Jean-Paul Terranova, Alexandre Urani, Christine Duarte, Vincent Santucci, Christiane Gueudet, Carole Voltz, Régis Steinberg, Jeanne Stemmelin, Florence Oury-Donat, Patrick Avenet, Guy Griebel and Bernard Scatton SSR180711, a Novel Selective 7 Nicotinic Receptor Partial Agonist: (II) Efficacy in Experimental Models Predictive of Activity Against Cognitive Symptoms of Schizophreniadoi:10.1038/sj.npp.1301188 Neuropsychopharmacology 32, 17-34 | Abstract | Full text | PDF | |
|
| Bruno Biton, Olivier E Bergis, Frédéric Galli, Alain Nedelec, Alistair W Lochead, Samir Jegham, Danielle Godet, Christophe Lanneau, Raphaël Santamaria, Françoise Chesney, Jacques Léonardon, Patrick Granger, Marc W Debono, Georg A Bohme, Frédéric Sgard, François Besnard, David Graham, Annick Coste, André Oblin, Olivier Curet, Xavier Vigé, Corinne Voltz, Liliane Rouquier, Josiane Souilhac, Vincent Santucci, Christiane Gueudet, Dominique Françon, Régis Steinberg, Guy Griebel, Florence Oury-Donat, Pascal George, Patrick Avenet and Bernard Scatton SSR180711, a Novel Selective 7 Nicotinic Receptor Partial Agonist: (1) Binding and Functional Profiledoi:10.1038/sj.npp.1301189 Neuropsychopharmacology 32, 1-16 | Abstract | Full text | PDF | |
|
| Jeanne Stemmelin, Caroline Cohen, Jean-Paul Terranova, Matilde Lopez-Grancha, Philippe Pichat, Olivier Bergis, Michel Decobert, Vincent Santucci, Dominique Françon, Richard Alonso, Stephen M Stahl, Peter Keane, Patrick Avenet, Bernard Scatton, Gérard le Fur and Guy Griebel Stimulation of the 3-Adrenoceptor as a Novel Treatment Strategy for Anxiety and Depressive Disordersdoi:10.1038/sj.npp.1301424 Neuropsychopharmacology 33, 574-587 | Abstract | Full text | PDF | |
|
| Scattoni, Maria Luisa |
|
| Marco Bortolato, Patrizia Campolongo, Regina Anne Mangieri, Maria Luisa Scattoni, Roberto Frau, Viviana Trezza, Giovanna La Rana, Roberto Russo, Antonio Calignano, Gian Luigi Gessa, Vincenzo Cuomo and Daniele Piomelli Anxiolytic-Like Properties of the Anandamide Transport Inhibitor AM404 doi:10.1038/sj.npp.1301061 Neuropsychopharmacology 31, 2652-2659 | Abstract | Full text | PDF | |
|
| Result page | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | 100 | 101 | 102 | 103 | |
|
| top |
|

q/11 Coupling in a Schizophrenia Endophenotype
3-Adrenoceptor as a Novel Treatment Strategy for Anxiety and Depressive Disorders
